Trial intelligence / Profile preview

Ganoderma lucidum spore polysaccharide capsules for chemotherapy-related appetite loss and fatigue in gastric and colorectal cancer

CTR20130919Phase 2Active

Sponsor
Nanjing Zhongke Group
Start
Oct 2013
Countries
1
01

Overview

A Phase 2 trial of ganoderma lucidum spore polysaccharide in gastric cancer (GC), colorectal cancer (CRC), sponsored by Nanjing Zhongke Group. Started Oct 2013; status: active.

02

Drugs

ganoderma lucidum spore polysaccharide
03

Conditions

gastric cancer (GC)colorectal cancer (CRC)

Beyond the preview

Go deeper on CTR20130919.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130919.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call